Aytu BioScience
Casey O'Bryant has a range of work experience in various roles and industries. Starting in 2009, Casey worked as an English Teacher in Japan until 2010. Afterwards, Casey worked as a Business Analyst at Trans-Trade, Inc. from 2011 to 2013. Casey then transitioned to First Command Financial Services, where they held the position of Sales Analyst II from 2013 to 2015.
In 2015, Casey joined Smith & Nephew as a Sales Analyst, specializing in sales analytics and reporting. They were later promoted to Senior Sales Strategy Analyst in 2016 and held this role until 2018.
Most recently, Casey joined Aytu BioPharma in 2018. They started as the Manager of Commercial Analytics and later became the Director of Commercial Analytics in 2019. Currently, they hold the position of Senior Director of Organizational Insights and Analytics.
Casey O'Bryant earned a Bachelor's Degree in Business Administration and Management, General from Trinity University from 2003 to 2007.
Aytu BioScience
2 followers
Aytu BioPharma (NASDAQ: AYTU) is a specialty pharmaceutical company with a growing commercial portfolio of prescription therapeutics and consumer health products, including ADHD and pediatrics medications. Their evolution has been driven by strategic in-licensing, acquisition-based transactions and organic product growth. As they continue on this trajectory, they are building a complimentary therapeutic development pipeline that will address significant unmet needs.